Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Vicor Forecast Q4 Profit At Essentially Breakeven Level - Quick Facts

RELATED NEWS
Trade VICR now with 

Vicor Corp. (VICR: Quote) Monday said it expects fourth-quarter earnings in an essentially break-even level, flat with prior-quarter. Based on existing backlog, the company has forecast a loss for the first quarter of 2013.

The company has been experiencing eight consecutive quarters of declining earnings, largely attributable to weak demands, lower volumes and higher expenses.

"In the fourth quarter of 2012, our bookings activity has slowed; through November 23. This reduction in orders has caused us to reassess our expectations for revenue and earnings for the fourth quarter of 2012 and the first quarter of 2013, " said Patrizio Vinciarelli, Vicor's Chairman of the Board and CEO.

Click here to receive FREE breaking news email alerts for Vicor Corp and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
United Nations Secretary-General Ban Ki-moon on Tuesday urged both Israelis and Palestinians to stop the fighting that has been raging for the past two weeks in the Gaza Strip, and pleaded with the two sides to return to dialogue with the aim of addressing the underlying causes of the repeated cycles... After moving notably higher in early trading on Tuesday, stocks continued to perform well throughout the session. The gains on the day offset the modest weakness that was seen in the previous session, extending the recent back-and-forth movement by the markets. Two federal appeals courts have issued contradictory rulings over the federal government's ability to provide subsidies under Obamacare, suggesting that the future of President Barack Obama's healthcare law could once again end up in the hands of the U.S. Supreme Court.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.